CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 2,429 target
Drug / intervention
Fractional flow reserveother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05250557
NCT05250557N/ARecruitingUpdate OverdueUpdated 52mo ago · Completion was 6mo ago
Enrollment Stalled
Long Recruiting
Update Overdue

Prognostic Impact of Lesion-specific Hemodynamic Index and Disease Characteristics in Patients With Coronary Artery Disease Assessed by Fractional Flow Reserve

Seoul National University Hospital·observational·Posted Feb 22, 2022·Updated Feb 22, 2022

In Brief

An observational study evaluating Fractional flow reserve for Coronary Artery Disease. Currently recruiting, targeting 2,429 participants across 1 site.

Signals

Enrollment appears stalled

Detailed Summary

The investigators aim to investigate the additive prognostic value of lesion-specific hemodynamic index such as ΔFFR, non-hyperemic pressure ratio such as RFR, over % diameter stenosis and FFR according to treatment strategy, and to find the prognostic implications of post-PCI FFR after adjustment of various clinical and disease characteristics, and to construct a comprehensive risk prediction model for post-PCI outcomes.

Study Details

Timeline

N/ARecruiting
202220232024202520262027
First PostedFeb 22, 2022
Enrollment StartAug 1, 2021
Primary CompletionDec 31, 2025
Study CompletionDec 31, 2026
TodayJul 1, 2026
Enrollment to primary: 4.4 yearsPosted 4.4 years ago

Interventions

Fractional flow reserveother

Physiologic assessment includes Δ FFR (lesion-specific) and FFR (vessel-specific) measurement. Δ FFR is defined as a pressure step up across the lesion. Coronary angiography and physiologic assessment will be analyzed by an independent core laboratory (Seoul National University Hospital, Clinical Trial Center, Seoul, South Korea).